Finally, antagonism of MAP3K19 by a small molecule inhibitor, or siRNA, can inhibit TGF-β signaling and target gene transcription as well as potently diminish bleomycin-induced lung fibrosis in a murine model of IPF. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.